Treatment with botulinum toxin improves upper-extremity function post stroke: A systematic review and meta-analysis

Archives of Physical Medicine and Rehabilitation

Volumn 94, Issue 5, 2013, Pages 977-989

  Foley, Norine ^a   Pereira, Shelialah ^a   Salter, Katherine ^a   Fernandez, Manuel Murie ^b   Speechley, Mark ^c   Sequeira, Keith ^c,d   Miller, Thomas ^a,c,d   Teasell, Robert ^a,c,d  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF NAVARRA   (Spain)

^c WESTERN UNIVERSITY   (Canada)

^d PARKWOOD HOSPITAL   (Canada)

Author keywords

Botulinum toxin type A; Meta analysis; Rehabilitation; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ARM; ARM DISEASE; ARM MOVEMENT; ARM SPASTICITY; CEREBROVASCULAR ACCIDENT; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; FINGER; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; REVIEW; SHOULDER; SPASTICITY; TREATMENT OUTCOME; WRIST;

BOTULINUM TOXINS, TYPE A; CONFIDENCE INTERVALS; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; STROKE; UPPER EXTREMITY;

EID: 84876679151     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2012.12.006     Document Type: Review

References (44)

1. J.W. Lance The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture Neurology 30 1980 1303 1313 (Pubitemid 11209184)
2. D.K. Sommerfeld, E.U. Eek, A.K. Svensson, L.W. Holmqvist, and M.H. von Arbin Spasticity after stroke: its occurrence and association with motor impairments and activity limitations Stroke 35 2004 134 139 (Pubitemid 38057606)
3. A.K. Welmer, H.L. Widen, and D.K. Sommerfeld Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke Eur J Neurol 17 2010 720 725
4. E. Lundstrom, A. Terent, and J. Borg Prevalence of disabling spasticity 1 year after first-ever stroke Eur J Neurol 15 2008 533 539 (Pubitemid 351677501)
5. C.L. Watkins, M.J. Leathley, J.M. Gregson, A.P. Moore, T.L. Smith, and A.K. Sharma Prevalence of spasticity post stroke Clin Rehabil 16 2002 515 522
6. A.K. Welmer, Arbin M. von, H.L. Widen, and D.K. Sommerfeld Spasticity and its association with functioning and health-related quality of life 18 months after stroke Cerebrovasc Dis 21 2006 247 253
7. E.L. Olvey, E.P. Armstrong, and A.J. Grizzle Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review Clin Ther 32 2010 2282 2303
8. D.M. Simpson, J.M. Gracies, and H.K. Graham Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 2008 1691 1698 (Pubitemid 351644137)
9. A.E. Elia, G. Filippini, D. Calandrella, and A. Albanese Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review Mov Disord 24 2009 801 812
10. A. Brashear, M.F. Gordon, and E. Elovic Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400 (Pubitemid 34851831)
11. A.M. Bakheit, S. Pittock, and A.P. Moore A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke Eur J Neurol 8 2001 559 565 (Pubitemid 35015221)
12. D.M. Simpson, D.N. Alexander, and C.F. O'Brien Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial Neurology 46 1996 1306 1310 (Pubitemid 26159292)
13. R.L. Rosales, and A.S. Chua-Yap Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity J Neural Transm 115 2008 617 623
14. E. Cardoso, B. Rodrigues, R. Lucena, I.R. Oliveira, G. Pedreira, and A. Melo Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis Arq Neuropsiquiatr 63 2005 30 33 (Pubitemid 40543413)
15. S.A. Yablon, M.F. Brin, and A.M. VanDenburgh Dose response with onabotulinumtoxin A for post-stroke spasticity: a pooled data analysis Mov Disord 26 2011 209 215
16. A.M. Bakheit, A.F. Thilmann, and A.B. Ward A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke Stroke 31 2000 2402 2406
17. S.J. Smith, E. Ellis, S. White, and A.P. Moore A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury Clin Rehabil 14 2000 5 13 (Pubitemid 30072216)
18. L. Ada, N. O'Dwyer, and E. O'Neill Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study Disabil Rehabil 28 2006 891 897
19. C.T. Leonard, K.A. Gardipee, J.R. Koontz, J.H. Anderson, and S.A. Wilkins Correlation between impairment and motor performance during reaching tasks in subjects with spastic hemiparesis J Rehabil Med 38 2006 243 249
20. H.P. Francis, D.T. Wade, L. Turner-Stokes, R.S. Kingswell, C.S. Dott, and E.A. Coxon Does reducing spasticity translate into functional benefit? An exploratory meta-analysis J Neurol Neurosurg Psychiatry 75 2004 1547 1551 (Pubitemid 39430605)
21. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 2008 457 507
22. National Stroke Foundation. Clinical guidelines for stroke management 2010. 2010. Available at: http://strokefoundation.com.au/site/media/clinical- guidelines
23. P.W. Duncan, R. Zorowitz, and B. Bates Management of adult stroke rehabilitation care: a clinical practice guideline Stroke 36 2005 e100 e143
24. P. Lindsay, G. Gubitz, and M. Bayley Canadian best practice recommendations for stroke care (updated 2010) 2010 Canadian Stroke Strategy Best Practices and Standards Writing Group Ottawa, Ontario, Canada Available at http://www.hsf.sk.ca/siss/documents/2010-BP-ENG.pdf Accessed March 17, 2012
25. L. Shaw, H. Rodgers, and C. Price BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A Health Technol Assess 14 26 2010
26. WHO. International Classification of Functioning, Disability and Health (ICF). 2001. Available at: http://www.who.int/classifications/icf/en/. Accessed March 18, 2012.
27. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
28. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
29. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Academic Pr New York
30. B.B. Bhakta, J.A. Cozens, M.A. Chamberlain, and J.M. Bamford Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial J Neurol Neurosurg Psychiatry 69 2000 217 221 (Pubitemid 30466027)
31. M.K. Childers, A. Brashear, and P. Jozefczyk Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke Arch Phys Med Rehabil 85 2004 1063 1069 (Pubitemid 38962361)
32. A. Suputtitada, and N.C. Suwanwela The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity Disabil Rehabil 27 2005 176 184 (Pubitemid 40468158)
33. F. Guo, W. Yue, L. Ren, Y. Zhang, and J. Yuang Botulinum toxin type A plus rehabilitative training for improving the motor function of the upper limbs and activities of daily life in patients with stroke and brain injury Neural Regeneration Res 1 2006 859 861 (Pubitemid 351606380)
34. A.W. Jahangir, H.J. Tan, and M.I. Norlinah Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke Med J Malaysia 62 2007 319 322 (Pubitemid 351437312)
35. P. Kanovsky, J. Slawek, and Z. Denes Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity Clin Neuropharmacol 32 2009 259 265
36. P. McCrory, L. Turner-Stokes, and I.J. Baguley Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes J Rehabil Med 41 2009 536 544
37. J.M. Meythaler, L. Vogtle, and R.C. Brunner A preliminary assessment of the benefits of the addition of botulinum toxin A to a conventional therapy program on the function of people with longstanding stroke Arch Phys Med Rehabil 90 2009 1453 1461
38. D.M. Simpson, J.M. Gracies, S.A. Yablon, R. Barbano, and A. Brashear Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study J Neurol Neurosurg Psychiatry 80 2009 380 385
39. R. Kaji, Y. Osako, K. Suyama, T. Maeda, Y. Uechi, and M. Iwasaki Botulinum toxin type A in post-stroke upper limb spasticity Curr Med Res Opin 26 2010 1983 1992
40. L.C. Shaw, C.I. Price, and F.M. van Wijck Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain Stroke 42 2011 1371 1379
41. E. Cousins, A. Ward, C. Roffe, L. Rimington, and A. Pandyan Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size Clin Rehabil 24 2010 501 513
42. D. Moher, B. Pham, and A. Jones Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 1998 609 613 (Pubitemid 28380142)
43. L.L. Kjaergard, J. Villumsen, and C. Gluud Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses Ann Intern Med 135 2001 982 989 (Pubitemid 33131619)
44. T. Platz, C. Eickhof, G. Nuyens, and P. Vuadens Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature Disabil Rehabil 27 2005 7 18 (Pubitemid 40124835)